Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 750 of 6351
-
Can 3D-Printed molds pinpoint cancer hotspots?
Knowledge-focused Recruiting nowDetermination of the sites from which the histopathological samples in surgically removed lesions are collected is still done by eye by a pathologist. As radiological determination of regions of interest has already proven useful in in vivo use cases, the implementation of sampli…
Sponsor: Tampere University Hospital • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
VR therapy shows promise for autism social skills
Symptom relief CompletedThe goal of this randomized clinical trial is to compare and learn about Virtual Reality (VR) in children with autism/Autistic children. The main question it aims to answer is: • Does the Floreo VR clinical product show clinical improvement in autism symptoms? Participants wil…
Sponsor: Floreo, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, immunogenicity , PK, and PD of a single dose of SR604 in participants with Hemophilia A or Hemophilia B, with or without inhibitors (Part A)and to evaluate the safety, PK, PD, and efficacy of multiple doses of SR6…
Phase 1/2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New 4-Drug cocktail aims to control Hard-to-Treat myeloma
Disease control Recruiting nowThe main goal of this phase II study is to evaluate the overall response rate of isatuximab, belantamab mafodotin, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma. The study drugs provided for research purposes are isatuximab and belantamab mafodotin.
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular degeneration (AMD). The main questions it aims to answer are: what is the rate of change in the macular area of photoreceptor loss in …
Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug may boost motor skills in kids with SMA after gene therapy
Disease control Recruiting nowThis is an open-label, single-arm, multicenter clinical study to evaluate the effectiveness and safety of risdiplam administered as an early intervention in pediatric participants with spinal muscular atrophy (SMA) and 2 SMN2 copies who have previously received onasemnogene abepa…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden ovarian cancer
Diagnosis Recruiting nowThis Phase 3 study is designed to investigate the safety, diagnostic performance, and clinical usefulness of Gleolan for the real-time detection and visualization of epithelial ovarian cancer tumors during debulking surgery. The study is planned to run for about 18 months with in…
Phase 3 • Sponsor: NX Development Corp • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Can a radioactive antibody light up hidden tumors on PET scans?
Diagnosis OngoingThis is an open-label pilot study of a new PET/CT imaging agent MNPR-101-DFO\*-89Zr in patients with solid tumor cancers. These cancers may include bladder/urothelial, triple-negative breast, lung, colorectal, gastric, ovarian, and pancreatic cancers. MNPR-101-DFO\*-89Zr is made…
Phase 1 • Sponsor: Monopar Therapeutics • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New trial aims to tailor breast cancer therapy using genetic tests
Disease control Recruiting nowThis study aims to utilize a novel biomarker-driven approach to guide neoadjuvant treatment selection. It is the hypothesis that this will improve clinical response for postmenopausal women with clinical stage II/III ER-positive, HER2-negative breast cancer and identify those who…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New liposomal drug combo aims to boost lymphoma remission
Disease control Recruiting nowThis is a prospective clinical study to evaluate the safety and efficacy of R-CMOP in patients with newly diagnosed diffuse large B-cell lymphoma
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Heart valve trouble? a diabetes drug may shield the heart muscle — trial puts it to the test
Disease control CompletedBackground: The aortic valve is like a door in the heart that lets blood flow out to the body. Over time, this valve can get worn out and become too narrow, leading to a condition called aortic stenosis. When this happens, the heart has to work extra hard to push blood through t…
Phase 2/3 • Sponsor: University of East Anglia • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New device aims to zap away chronic migraine pain
Symptom relief OngoingProspective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.
Sponsor: ShiraTronics • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Fewer eye injections possible? new study tests Higher-Dose aflibercept for DME
Disease control CompletedResearchers are looking for a better way to treat people who have diabetic macular edema. Diabetic macular edema (DME) is a diabetes-related eye disorder. In DME, the macula, which is the central part of the retina at the back of the eye, swells up resulting in vision problems. …
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to help kids with stiff heart muscle breathe easier
Disease control OngoingThe purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
Phase 2/3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Immunotherapy plus chemo takes on tough breast cancer
Disease control Recruiting nowTo look at the effectiveness of the combination of pembrolizumab, carboplatin, and paclitaxel in participants with stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered immune cells take on advanced cancers in early trial
Disease control Recruiting nowA clinical trial to assess the safety and efficacy of engineered Tumor Infiltrating Lymphocytes (TIL) for the treatment of Advanced Malignant Solid Tumors
Phase 1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for advanced cancer patients with CLDN18.2 marker
Disease control Recruiting nowThis study consists of two research phases: Phase Ib (includes dose escalation stage and efficacy expansion stage): To explore the safety, tolerability and initial efficacy of SHR-A1904 in the treatment of CLDN18.2-positive advanced solid tumors, and to determine the recommended…
Phase 1 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can virtual reality make knee pain therapy more engaging?
Symptom relief CompletedOne of the main challenges facing the therapist in the treatment of adhesive capsulitis is to motivate the patient throughout conventional therapy. As noted in a recent review, individuals are more interested in leisure activities rather than performing repetitive tasks during th…
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Wolbachia-Infected mosquitoes released to fight dengue, zika, and chikungunya
Prevention Stopped earlyMosquito-borne diseases cause suffering for hundreds of millions of people and claim more than 700,000 lives yearly. Diseases such as dengue, Zika, and chikungunya cause symptoms similar to malaria and are endemic in many parts of the world, yet there are no treatments for them n…
Sponsor: Michigan State University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to prevent Life-Threatening birth complications in black and hispanic mothers
Disease control Recruiting nowThe purpose of this study is to test the effectiveness of an integrated care model approach at two different levels of intensity designed to facilitate timely, appropriate care to reduce risk for SMM. Black and Hispanic pregnant patients with an Obstetrics-Comorbidity Index Score…
Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC